Cardiology

LARC deemed safe for women with cardiovascular conditions

(HealthDay)—For women with cardiovascular conditions, long-acting reversible contraception (LARC) appears safe with few complications, according to a study published in the Jan. 15 issue of The American Journal of Cardiology.

Diseases, Conditions, Syndromes

Proteins discovered in gonorrhea may offer new approach to treatment

Researchers at Oregon State University have discovered novel proteins in, or on the surface of the bacteria that causes gonorrhea, which offer a promising new avenue of attack against a venereal disease that is showing increased ...

Diseases, Conditions, Syndromes

Few pregnant women treated for sexually transmitted infections

Many pregnant women with sexually transmitted infections aren't getting the treatment they need when they visit emergency rooms, according to a new Michigan State University study that highlights a wholly preventable risk ...

Diseases, Conditions, Syndromes

Rise of antibiotic-resistant gonorrhea needs urgent action

Gonorrhea is evolving into a scourge resistant to most antibiotics, and urgent action is needed to combat this public health threat, states an editorial in CMAJ (Canadian Medical Association Journal).

Diseases, Conditions, Syndromes

Possible 'superbug' status for sexually-transmitted infection

The rise of multidrug resistance in gonorrhoea-causing bacteria is threatening to make this sexually-transmitted infection extremely difficult to treat. Professor Catherine Ison, speaking at the Society for General Microbiology's ...

Medications

Bayer receives FDA approval for long-term contraceptive

(HealthDay)—Bayer HealthCare has received approval from the U.S. Food and Drug Administration for its new low-dose levonorgestrel-releasing intrauterine system (IUS) called Skyla, according a Jan. 10 news release issued ...

page 3 from 12